These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2086909)

  • 1. [Clinical significance of Lewis blood-group phenotype and serum CA-19-9 analysis in the diagnosis of diabetic diseases].
    Shimojo N; Okuda K
    Nihon Rinsho; 1990 Dec; 48 Suppl():359-64. PubMed ID: 2086909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of blood group antigen in sera as a tumor marker].
    Imai K; Arimura Y; Yachi A
    Nihon Rinsho; 1990 Feb; 48 Suppl():912-6. PubMed ID: 1972427
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of 2-6 sialyl Le(a) antigen assay as a tumor marker].
    Kannagi R; Itai S; Harada R
    Nihon Rinsho; 1990 Feb; 48 Suppl():1045-52. PubMed ID: 2355503
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of urinary growth hormone in the diagnosis of diabetes mellitus].
    Fushimi H; Inoue T; Kameyama M
    Nihon Rinsho; 1990 Dec; 48 Suppl():498-504. PubMed ID: 2086927
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.
    Tempero MA; Uchida E; Takasaki H; Burnett DA; Steplewski Z; Pour PM
    Cancer Res; 1987 Oct; 47(20):5501-3. PubMed ID: 3308077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of serum prolyl hydroxylase analysis in the diagnosis of diabetic diseases].
    Shioi A; Nishizawa Y; Morii H
    Nihon Rinsho; 1990 Dec; 48 Suppl():370-3. PubMed ID: 1964975
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of carbohydrate antigen 19-9 assay as a tumor marker].
    Ohkura H; Sakawaki T; Hara K; Mitsuhashi F
    Nihon Rinsho; 1990 Feb; 48 Suppl():931-3. PubMed ID: 2192177
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lewis antigens and CA19-9].
    Naka K; Shimojo N
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():117-20. PubMed ID: 9513400
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of serum sialic acid in the diagnosis of diabetic diseases].
    Nishimura S; Nanjo K
    Nihon Rinsho; 1990 Dec; 48 Suppl():349-52. PubMed ID: 2086908
    [No Abstract]   [Full Text] [Related]  

  • 10. Sialyl Lewis-Xi antigen in patients with gynecologic tumors.
    Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saito J; Tanizawa O
    Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2 --> 6 sialyl Le(a) antigen].
    Miyazaki K; Kannagi R
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():703-8. PubMed ID: 20960854
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
    Shimano T; Morimoto H; Saito M; Mori T
    Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K; Okura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nonprogressive and progressive diabetes mellitus].
    Horiuchi A
    Nihon Rinsho; 1967 Feb; 25(2):246-50. PubMed ID: 6069397
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type.
    Pour PM; Tempero MM; Takasaki H; Uchida E; Takiyama Y; Burnett DA; Steplewski Z
    Cancer Res; 1988 Oct; 48(19):5422-6. PubMed ID: 3166398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of CA 15-3 assay as a tumor marker].
    Goto M; Adachi I
    Nihon Rinsho; 1990 Feb; 48 Suppl():967-70. PubMed ID: 2355637
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--2. Evaluation of clinical significance].
    Imura H; Takahashi T; Matsuda T; Yoshida O; Ohkura H; Seitetsu Y; Seino Y; Ishii M; Kuwabara M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2203-12. PubMed ID: 2660749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2-->6 Sialyl Le(a) antigen].
    Miyazaki K; Kannagi R
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pancreatic cancer and tumor markers].
    Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
    Rinsho Byori; 1991 Jun; Suppl 89():58-72. PubMed ID: 1680205
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of CA 130 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M
    Nihon Rinsho; 1990 Feb; 48 Suppl():985-8. PubMed ID: 2355640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.